Indications and uses
For the relief of symptoms due to Candida, specific for drainage
For the relief of symptoms due to Candida, specific for drainage
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Caffeic acid 6X 200K, Candida Albicans 30X 200K, Chrysanthemum parthenium 30X, 200K, Hydrocotyle Asiatica 6X 200K, Mannan 6X 200K, Vaccinium Vitis Idaea 12X 200K, Vaccinium Vitis Idaea 2X
| Caffeic acid | Urogenital drainage |
| Candida Albicans | Dysbiosis |
| Chrysanthemum parthenium | Neurological support |
| Hydrocotyle Asiatica | Drainage |
| Mannan | Drainage |
| Vaccinium Vitis Idaea | Intestinal balance |
| Vaccinium Vitis Idaea | Intestinal balance |
For the relief of symptoms due to Candida, specific for drainage
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
Alcohol and Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0071
NDC 63776-075-15
Homeopathic remedy
Candida I
• For the relief of symptoms due to Candida, specific for drainage
Oral spray
50ml 1.7 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Candida I
50 mL
1.7 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0071
NDC: 63776-075-15
INDICATIONS:
For the relief of symptoms due to Candida, specific for drainage
DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-075-15 | 2024-01-30 | C162847 | 48780-1 | 1030e365-581b-111a-e063-dadaa90a10e2 | Candida I |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-075-15 | Candida I | 1 in 1 BOX | SPRAY | 1 | 5 | |
| 63776-075-15 | Candida I | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-075 | CANDIDA I (CAFFEIC ACID, CANDIDA ALBICANS, TANACETUM PARTHENIUM, CENTELLA ASIATICA, YEAST MANNAN, PENICILLIN G, VACCINIUM VITIS-IDAEA LEAF SPRAY) SPRAY [VIATREXX BIO INCORPORATED] | 5 | Legacy NDC, 2 package rows | 20220120_3bcd0f39-cd5d-87a0-3223-2d7495b4d7e0.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Caffeic Acid | ACTIVE INGREDIENT | U2S3A33KVM | 1 | |
| Candida Albicans | ACTIVE INGREDIENT | 4D7G21HDBC | 1 | |
| Centella Asiatica | ACTIVE INGREDIENT | 7M867G6T1U | 1 | |
| Penicillin G | ACTIVE INGREDIENT | Q42T66VG0C | 1 | |
| Tanacetum Parthenium | ACTIVE INGREDIENT | 6GE7Z0761K | 1 | |
| Vaccinium Vitis-idaea Leaf | ACTIVE INGREDIENT | FO2ACM0RMQ | 1 | |
| Yeast Mannan | ACTIVE INGREDIENT | 91R887N59P | 1 | |
| Caffeic Acid | ACTIVE MOIETY | U2S3A33KVM | 1 | |
| Candida Albicans | ACTIVE MOIETY | 4D7G21HDBC | 1 | |
| Centella Asiatica | ACTIVE MOIETY | 7M867G6T1U | 1 | |
| Penicillin G | ACTIVE MOIETY | Q42T66VG0C | 1 | |
| Tanacetum Parthenium | ACTIVE MOIETY | 6GE7Z0761K | 1 | |
| Vaccinium Vitis-idaea Leaf | ACTIVE MOIETY | FO2ACM0RMQ | 1 | |
| Yeast Mannan | ACTIVE MOIETY | 91R887N59P | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-075 | 63776-075-15 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| CAFFEIC ACID | U2S3A33KVM | ACTIB |
| CANDIDA ALBICANS | 4D7G21HDBC | ACTIB |
| TANACETUM PARTHENIUM | 6GE7Z0761K | ACTIB |
| CENTELLA ASIATICA | 7M867G6T1U | ACTIB |
| YEAST MANNAN | 91R887N59P | ACTIB |
| VACCINIUM VITIS-IDAEA LEAF | FO2ACM0RMQ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d5f3994d-318b-4c03-e053-2995a90ae6e2 | 3bcd0f39-cd5d-87a0-3223-2d7495b4d7e0 | 2022-01-19 | Warnings | d5f3994d-318b-4c03-e053-2995a90ae6e2 3bcd0f39-cd5d-87a0-3223-2d7495b4d7e0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.